Back in September 2008, two cases in a span of two days prompted me to ask (in “Enforcement Action, Oncology Edition“) “which is worse — inducing shareholders to purchase $6.5 million of your company’s stock by falsely depicting the company as being on the verge of success curing cancer? Or defrauding a federal judge by falsely depicting yourself as having cancer such that you are so ill that you cannot participate in a potential SEC case against you?”
Well, the key player in the latter half of that question has now come clean. Get all the details in this post on my Enforcement Action blog over at Compliance Week.
